Introduction
Identification of the human genetic health hazard from exposure to chemicals of a diverse nature is of significant importance from a public health standpoint. A wide variety of organisms ranging from phage to human cells in culture may be used as tester strains to identify the mutagenic capability of a chemical. While these systems do supply genetically useful information, their major limitation is their inability to consider host biotransformation and other pharmacokinetic parameters. This is of especial importance if the derived data is to have human relevance. While the most ideal situation would be to study man himself, the major limitation to this approach would be of a practical and ethical nature. vious advantages. The L5178Y murine leukemia has been relatively unexplored in the area of mutagenicity testing but it has a number of favorable attributes which enhance its utility as an indicator organism. These are as follows: (1) It-grows well in vitro as a single cell suspension-with a doubling time in the range of 10-12 hr (1) . ( Good cloning results are dependent on careful control of the pH during development of the clones. The medium should be at approximately pH 7.0 at the time of cloning. This may be achieved by adjustment of the pH of the medium when prepared from powder or concentrate (with storage in tightly capped containers to prevent loss of CO2), or by addition of sterile OJN HC1 to the medium at the time of cloning to bring the medium to a yellow-orange color. Clones develop with poor efficiency when CO2 is lost and cultures become alkaline. Thus, the cultures must be tightly capped or incubated in a 5%o CO2 incubator. With careful technique, 70-90% cloning efficiency was routinely obtained.
Determination of the asn-independent mutant frequency was performed in a similar manner, except that F-S1, medium was used, and a total of 2.5-5.0 x 105 cells were cloned in the 5-ml cultures, or 5 x 108 cells in 15 ml in the 30-ml Falcon flasks. Reconstruction experiments indicated that the plating efficiency and recovery of mutants were not affected until the concentration of cells exceeded 5 x 105 per 5 ml culture, or 7 x 106 per 15 ml culture in the Falcon flasks.
For the in vivo studies, ascites cells were removed aseptically by injecting 5 ml of F-S1o through the exposed peritoneum and aspirating as much fluid as possible. The suspension was diluted to 50 ml, centrifuged at room temperature for 10 min at 250g, and the cells were washed twice with F-S15. Finally, the cell pellet was diluted with sufficient F-S15 to provide a cell titer of (6, 7) . The methods for measurement of t-h-e level of asn synthetase activity in subcellular preparations and of the accumulation of asn during short-term incubation of whiole cells at high density were previously described by Chou and Handschumacher (11) .
Results
The spontaneous mutation rate to asn independence was determined by using the fluctuation test as described by Luria and Delbruck (12) . By using eq. (8) of Luria and Delbruck (11) with the aid of tables as described by Capizzi and Jameson (13) , the in vitro mutation rate of L5178Y/asn-to L5178Y/asn+ was found to be 7.4 and 9 x 10-7/cell/generation in two independent investigations (RLC and WPS, respectively). Fluctuation tests performed with clones adapted to in vivo growth yielded a mutation rate of 9.9 x 10-7/cell/ generation.
Mutations to asn independence have been induced by mutagens known to produce either base pair substitution or frameshift mutations. Dose-response data for the bifunctional alkylating agent sulfur mustard (SM) are shown in Table 1 . L5178Y/asncells were plated in F-S15 immediately after 30 min of exposure to sulfur mustard. A nonlethal dose of SM (0.001 ug/ml) failed to increase the mutant frequency. However, as cytotoxicity increased, so did the mutant frequency.
The induction of mutation with other known mutagens is shown in Table 2 . L5178Y/asn-were exposed to various agents in vitro, then washed and incubated in fresh, a L5178Y/asn-were exposed to sulfur mustard for 30 min, washed twice, then cloned for the determination of viability and mutant frequency (MF). complete medium for 42-48 hr to allow "expression" of the mutation prior to cloning in the selection medium (F-S15). An increase in mutant frequency was produced by the alkylating agents ethyl methanesulfonate (EMS) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) as well as the frameshift mutagen ICR-372, 2-methoxy-6-chloro-9-[3-(2-chloroethyl) aminopropylamino] 1-azaacridine dihydrochloride.
Environmental Health Perspectives
The utility of the host-mediated assay with the use of the L5178Y ascites tumor is indicated with studies with dimethyl nitrosamine (DMNA). Four days after the intraperitoneal implantation of the L5178Y/ asn-, the mice were treated with a single subcutaneous dose of DMNA. At 6 and 96 hr after treatment, the cells were harvested, washed twice with F-S15, and cloned for viability in F+S15 and for mutant frequency in F-S15. As is shown in Figure 2 , when the cells were assayed 6 hr after treatment, no increase in mutants was produced by 2.5 mg/kg, and only a slight increase was produced by 5 Spontaneous asn+ mutants have been studied in detail with respect to growth kinetics and asparagine synthetase levels (7) . Although asn+ clones extracted from F-S15 grow at near the optimal rate in F-S10 upon serial passage, it was repeatedly observed that the growth rate was not identical to the L5178Y/ asn-for the first few weeks passage in the asn-less medium. To further characterize the properties of newly derived spontaneous mutants, clonal isolates were maintained under nonselective conditions (i.e., in F+S1O) except during the selective cloning step. This procedure revealed that the initial mutation does not impart total asn independence. This is evident by a slower, nonpopulation-dependent growth rate (20-24 hr) of the cells when subcultured in asn-less medium. They resume the 10-11 hr doubling time within 16-24 hr. This was observed in the newly isolated clones and has remained unchanged after many passages in F+S,o. The serial passage of mutant substrains in F-S,O produced asn+ lines whose growth was identical in the presence and absence of asn.
The specific activity of the enzyme, asparagine synthetase, correlated with these cell growth patterns. The enzyme activity in newly isola-ted clones and in the progeny of mutant clones maintained in F+S1. for periods in excess of a year was approximately 4 nmole/mg protein/hr compared to <0.7 nmole/mg protein-hr in the parental, L5178Y/asn-cells. However, the increase in growth rate after continuous subculture in F-S0n was associated with a significant increase in the asn synthetase activity (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) nmole asn/mg protein-hr in various fully adapted asn+ lines). This level was not decreased by growing the cells in asn-supplemented medium (F+S1o).
Thus the original mutation is to an intermediate level of asn synthetase and the further transition to complete asn-independence may require further mutation and selection. Growth studies and asn synthetase assays on mutants induced by MNNG, EMS, and ICR-372 indicated that these mutants had the same characteristics as the initial spontaneous mutants.
Discussion
The applicability and utility of various nonmammalian and mammalian tester strains for the detection of chemical mutagens have been discussed in several recent texts (14) (15) (16) . Although the L5178Y murine leukemia has not been extensively investigated, several recent reports have indicated the applicability of the thymidine kinase locus (17) and resistance to MTX, Ara-c and IUDR (18) as genetic markers for the detection of chemical mutagens.
The susceptibility of the asn locus to mutation by chemicals known to produce frameshift mutations and mutations by base-pair substitutions suggests that the observed change in phenotype from auxotrophy to prototrophy might not be a "reverse" mutation but rather a "forward" mutation involving the inactivation of a repressor or inhibitor. This observed mutability of the asn locus by known chemical mutagens warrants further exploration.
